Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

1(13%)

Results Posted

17%(1 trials)

Phase Distribution

Ph phase_2

13%

Ph not_applicable

88%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

1(12.5%)

N/ANon-phased studies

7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(6)

Other(1)

Detailed Status

Completed6

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (12.5%)

N/A7 (87.5%)

Trials by Status

unknown113%

recruiting113%

completed675%

Recent Activity

1 active trials

Showing 5 of 8

completedphase_2

Clinical Trials (8)

Showing 8 of 8 trials

NCT00687115Phase 2

Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting

Completed

NCT04583514Not Applicable

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

Recruiting

NCT03857048Not Applicable

Adaptive Responses to Overfeeding and Weight

Unknown

NCT01672632Not Applicable

Fat Cell Size and Overfeeding and Etopic Study

Completed

NCT02809482Not Applicable

White Adipose Tissue Clocks and High Calorie Feeding

Completed

NCT02456870Not Applicable

Expandability of Aging Adipose Tissue

Completed

NCT01184170Not Applicable

Metabolically Normal and Metabolically Abnormal Obesity

Completed

NCT00355784Not Applicable

Growth Hormone as a Determinant of Weight Regulation

Completed

All 8 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 8